Stefan Faderl

Research interests

Publications

• Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab

  Blood · 2016 · https://doi.org/10.1182/blood-2016-09-736686

• Long‐term follow‐up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with P hiladelphia chromosome–positive acute lymphoblastic leukemia

  Cancer · 2015 · https://doi.org/10.1002/cncr.29646

• Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study

  The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)00207-7

• Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia

  Cancer · 2013 · https://doi.org/10.1002/cncr.28136

• Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study

  The Lancet Oncology · 2012 · https://doi.org/10.1016/s1470-2045(11)70386-2

• Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.38.9429

• Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia

  Blood · 2011 · https://doi.org/10.1182/blood-2011-03-339077

• Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia

  Blood · 2010 · https://doi.org/10.1182/blood-2010-03-276485

• Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients

  Blood · 2008 · https://doi.org/10.1182/blood-2008-05-157065

• Phase 1/2 study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemia

  Blood · 2006 · https://doi.org/10.1182/blood-2006-03-009142

• Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high‐risk myelodysplastic syndrome:

  Cancer · 2006 · https://doi.org/10.1002/cncr.21723

• Adult Acute Lymphoblastic Leukemia

  Mayo Clinic Proceedings · 2005 · https://doi.org/10.4065/80.11.1517

• Results of Intensive Chemotherapy in 998 Patients Aged 65 Years or Older with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome - Predictive Prognostic Models for Outcome.

  Blood · 2005 · https://doi.org/10.1182/blood.v106.11.1846.1846

• Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies

  Blood · 2003 · https://doi.org/10.1182/blood-2003-03-0687

• The Biology of Chronic Myeloid Leukemia

  New England Journal of Medicine · 1999 · https://doi.org/10.1056/nejm199907153410306

Current projects

No projects listed.